Zimbabwe has rejected a significant US healthcare agreement valued at $367m (272 million pounds) spanning five years over the United States' demand for sensitive information.
This rejection was revealed after a government memo from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the deal was "lopsided".
A government representative later explained that the United States was requesting biological samples for research and commercial purposes but was unwilling to share the benefits from future vaccines.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had furnished more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for continued talks to reach a agreement suitable to all parties so the nation's vital HIV programme can proceed.
Wider Implications
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a high court halted a related health funding agreement following legal challenges were raised about the safety of citizens' health data.
After returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and accountability.
Based on statements, 16 African countries have so far signed similar health pacts, constituting over $18.3bn in new funding.
Details of the Rejected Deal
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Zimbabwe was being asked to share its biological resources and data for a long time, without any corresponding promise of access to any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," his statement read.
"Put simply, our nation would supply the basic resources for medical research with no certainty that the resulting innovations would be available to our population should a future health crisis arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the global health body and its push of one-on-one deals were undermining frameworks previously established via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage future global health emergencies.
"This system is designed to guarantee that when a country contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to create them."
These objections over the US deal "are not meant as anti-American sentiment," he added.
"We welcome continued discussions with our US partners on how subsequent collaboration could be structured in a manner that honours the sovereignty and interests of each country."
Medical Community Response
A leading public health body stated it understood the official position, but urged that talks need to persist considering a large portion of the country's Aids initiatives depended on foreign aid.
"If specific concerns exist, such as those involving data governance or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," it said.
The situation emphasises the continuing challenges between receiving crucial foreign assistance and protecting a country's data in an increasingly interconnected world.